TMX Newsfile

IN THE PRESS

Defence’s Successful Submission of an Investigational New Drug (IND) Application for AccuTOX(R) as an Injectable Anticancer Treatment for Solid Tumors

November 14, 2023

·

5 min read

Policy

Awakn Life Sciences Announces Receipt of Notice of Non-Compliance with Cboe Exchange Continued Listing Requirements

November 13, 2023

·

4 min read

NervGen Pharma Reports Q3 2023 Financial Results and Operational Updates

November 9, 2023

·

9 min read

Business

PurMinds Appoints Leading Drug Designer, Dr. Alan Kozikowski, to Chief Scientific Officer and Appoints Pharma Veteran Dr. Max Arella to Scientific Advisory Board

November 9, 2023

·

6 min read

Business

Cell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating Officer

November 9, 2023

·

3 min read

Kiora Pharmaceuticals Reports Q3 2023 Results; Expanding Clinical Development of KIO-301 for Inherited Retinal Diseases Based on Encouraging Results of ABACUS-1 Study in Retinitis Pigmentosa

November 9, 2023

·

7 min read

MustGrow to Present at the Harbor Access Global SMID Cap Investor Conference November 16th

November 9, 2023

·

5 min read

Medexus Announces Strong Fiscal Q2 2024 Results, Including Quarterly Revenue of US$30.3 Million

November 9, 2023

·

18 min read

PharmaDrug Inc. Announces Grant of Stock Options

November 9, 2023

·

4 min read

Pharm Country

Adaptimmune Reports Third Quarter Financial Results and Business Update

November 8, 2023

·

17 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750